Advertisement

Improving Surgical Outcomes and Patient Health: Perioperative Smoking Cessation Interventions

  • 8 Accesses

Abstract

Purpose of Review

This review is aimed at discussing the evidence for perioperative smoking cessation interventions and at describing the components of an effective, multimodal smoking cessation intervention.

Recent Findings

The increased risks associated with smoking around the time of surgery are well established. There is strong evidence for the benefits of perioperative smoking cessation interventions, which include increasing smoking abstinence and decreasing surgical complications. Interventions should aim to start at least 4 weeks preoperatively and provide ongoing support; however, starting any time before or after surgery is beneficial. Collaboration between multiple healthcare providers is important. Accessible patient education tools and appropriate pharmacotherapy are useful adjuvants.

Summary

Perioperative smoking cessation interventions have proven benefits and should be implemented. This review describes and provides evidence for the various components of a multimodal perioperative smoking cessation program.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Gronkjaer M, Eliasen M, Skov-Ettrup LS, Tolstrup JS, Christiansen AH, Mikkelsen SS et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2014;259(1):52–71. doi:https://doi.org/10.1097/SLA.0b013e3182911913.

  2. 2.

    Turan A, Mascha EJ, Roberman D, Turner PL, You J, Kurz A et al. Smoking and perioperative outcomes. Anesthesiology. 2011;114(4):837–46. doi:https://doi.org/10.1097/ALN.0b013e318210f560.

  3. 3.

    • Nolan MB, Warner DO. Perioperative tobacco use treatments: putting them into practice. BMJ (Clinical research ed). 2017;358:j3340. doi:https://doi.org/10.1136/bmj.j3340. A review of smoking cessation interventions with a focus on implementation science.

  4. 4.

    Turan A, Koyuncu O, Egan C, You J, Ruetzler K, Sessler DI et al. Effect of various durations of smoking cessation on postoperative outcomes: a retrospective cohort analysis. Eur J Anaesthesiol. 2018;35(4):256–65. doi:https://doi.org/10.1097/EJA.0000000000000701.

  5. 5.

    Berlin NL, Cutter C, Battaglia C. Will preoperative smoking cessation programs generate long-term cessation? A systematic review and meta-analysis. Am J Manag Care. 2015;21(11):e623–31.

  6. 6.

    Lee SM, Landry J, Jones PM, Buhrmann O, Morley-Forster P. Long-term quit rates after a perioperative smoking cessation randomized controlled trial. Anesth Analg. 2015;120(3):582–7. doi:https://doi.org/10.1213/ANE.0000000000000555.

  7. 7.

    •• Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014(3):Cd002294. doi:https://doi.org/10.1002/14651858.CD002294.pub4. A Cochrane meta-analysis on the efficacy of perioperative smoking cessation interventions.

  8. 8.

    Glassman SD, Anagnost SC, Parker A, Burke D, Johnson JR, Dimar JR. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine. 2000;25(20):2608–15.

  9. 9.

    Nasell H, Adami J, Samnegard E, Tonnesen H, Ponzer S. Effect of smoking cessation intervention on results of acute fracture surgery: a randomized controlled trial. J Bone Joint Surg Am. 2010;92(6):1335–42. doi:https://doi.org/10.2106/JBJS.I.00627.

  10. 10.

    Shi Y, Warner DO. Surgery as a teachable moment for smoking cessation. Anesthesiology. 2010;112(1):102–7. https://doi.org/10.1097/ALN.0b013e3181c61cf9.

  11. 11.

    Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S, Nasell H et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008;248(5):739–45. doi:https://doi.org/10.1097/SLA.0b013e3181889d0d.

  12. 12.

    Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002;359(9301):114–7.

  13. 13.

    • Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth. 2012;59(3):268–79. doi:https://doi.org/10.1007/s12630-011-9652-x. A meta-analysis of observational studies examining the risks and benefits of short-term preoperative smoking cessation.

  14. 14.

    Warner DO. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology. 2006;104(2):356–67. https://doi.org/10.1097/00000542-200602000-00023.

  15. 15.

    • Nolan MB, Martin DP, Thompson R, Schroeder DR, Hanson AC, Warner DO. Association between smoking status, preoperative exhaled carbon monoxide levels, and postoperative surgical site infection in patients undergoing elective surgery. JAMA Surg. 2017;152(5):476–83. doi:https://doi.org/10.1001/jamasurg.2016.5704. A large observational study demonstrating that smoking on the day of surgery is associated with the development of surgical site infections.

  16. 16.

    Warner DO, Colligan RC, Hurt RD, Croghan IT, Schroeder DR. Cough following initiation of smoking abstinence. Nicotine Tob Res. 2007;9(11):1207–12. https://doi.org/10.1080/14622200701648920.

  17. 17.

    • Wong J, Abrishami A, Riazi S, Siddiqui N, You-Ten E, Korman J et al. A perioperative smoking cessation intervention with varenicline, counseling, and fax referral to a telephone quitline versus a brief intervention: a randomized controlled trial. Anesth Analg. 2017;125(2):571–9. doi:https://doi.org/10.1213/ane.0000000000001894. A RCT comparing a high-intensity perioperative smoking cessation intervention using varenicline with a brief intervention.

  18. 18.

    Rice VH, Heath L, Livingstone-Banks J, Hartmann-Boyce J. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2017;12:Cd001188. doi:https://doi.org/10.1002/14651858.CD001188.pub5.

  19. 19.

    Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013(5):Cd000165. doi:https://doi.org/10.1002/14651858.CD000165.pub4.

  20. 20.

    Yousefzadeh A, Chung F, Wong DT, Warner DO, Wong J. Smoking cessation: the role of the anesthesiologist. Anesth Analg. 2016;122(5):1311–20. https://doi.org/10.1213/ane.0000000000001170.

  21. 21.

    A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. American journal of preventive medicine. 2008;35(2):158–76. doi:https://doi.org/10.1016/j.amepre.2008.04.009.

  22. 22.

    Warner DO. Feasibility of tobacco interventions in anesthesiology practices: a pilot study. Anesthesiology. 2009;110(6):1223–8. https://doi.org/10.1097/ALN.0b013e3181a5d03e.

  23. 23.

    Vidrine JI, Shete S, Cao Y, Greisinger A, Harmonson P, Sharp B, et al. Ask-advise-connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013;173(6):458–64. https://doi.org/10.1001/jamainternmed.2013.3751.

  24. 24.

    Newhall K, Suckow B, Spangler E, Brooke BS, Schanzer A, Tan T-W, et al. Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease. Ann Vasc Surg. 2017;38:113–21. https://doi.org/10.1016/j.avsg.2016.06.005.

  25. 25.

    Reinbold C, Rausky J, Binder JP, Revol M. Urinary cotinine testing as pre-operative assessment of patients undergoing free flap surgery. Ann Chir Plast Esthet. 2015;60(1):e51–7. https://doi.org/10.1016/j.anplas.2014.10.002.

  26. 26.

    Warner DO, Sarr MG, Offord KP, Dale LC. Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period. Anesth Analg. 2004;99(6):1766–73, table of contents. doi:https://doi.org/10.1213/01.ane.0000136773.40216.87.

  27. 27.

    Lee SM, Landry J, Jones PM, Buhrmann O, Morley-Forster P. The effectiveness of a perioperative smoking cessation program: a randomized clinical trial. Anesth Analg. 2013;117(3):605–13. doi:https://doi.org/10.1213/ANE.0b013e318298a6b0.

  28. 28.

    Wong J, Abrishami A, Yang Y, Zaki A, Friedman Z, Selby P, et al. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology. 2012;117(4):755–64.

  29. 29.

    O’Loughlin J, Makni H, Tremblay M, Lacroix C, Gervais A, Dery V, et al. Smoking cessation counseling practices of general practitioners in Montreal. Prev Med. 2001;33(6):627–38. https://doi.org/10.1006/pmed.2001.0937.

  30. 30.

    van Eerd EAM, Bech Risor M, Spigt M, Godycki-Cwirko M, Andreeva E, Francis N, et al. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. NPJ primary care respiratory medicine. 2017;27(1):41. https://doi.org/10.1038/s41533-017-0038-6.

  31. 31.

    Tønnesen H, Faurschou P, Ralov H, Mølgaard-Nielsen D, Thomas G, Backer V. Risk reduction before surgery. The role of the primary care provider in preoperative smoking and alcohol cessation. BMC Health Serv Res. 2010;10:121-. doi:https://doi.org/10.1186/1472-6963-10-121.

  32. 32.

    Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Stewart D. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84(9):1883–905. https://doi.org/10.1111/bcp.13624.

  33. 33.

    • Beaupre LA, Hammal F, DeSutter C, Stiegelmar RE, Masson E, Finegan BA. Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery. Tobacco Induced Diseases. 2019;17(February). doi:https://doi.org/10.18332/tid/101600. A novel study demonstrating the benefits and feasibility of referring to a community pharmacy smoking cessation program as part of preoperative care.

  34. 34.

    Warner DO, Klesges RC, Dale LC, Offord KP, Schroeder DR, Vickers KS, et al. Telephone quitlines to help surgical patients quit smoking patient and provider attitudes. Am J Prev Med. 2008;35(6 Suppl):S486–93. https://doi.org/10.1016/j.amepre.2008.08.032.

  35. 35.

    Webb AR, Robertson N, Sparrow M. Smokers know little of their increased surgical risks and may quit on surgical advice. ANZ J Surg. 2013;83(10):753–7. doi:https://doi.org/10.1111/ans.12096.

  36. 36.

    Webb AR, Robertson N, Sparrow M, Borland R, Leong S. Printed quit-pack sent to surgical patients at time of waiting list placement improved perioperative quitting. ANZ J Surg. 2014;84(9):660–4. doi:https://doi.org/10.1111/ans.12519.

  37. 37.

    Wong J, Raveendran R, Chuang J, Friedman Z, Singh M, Patras J et al. Utilizing Patient E-learning in an Intervention Study on Preoperative Smoking Cessation. Anesth Analg. 2018;126(5):1646–53. doi:https://doi.org/10.1213/ANE.0000000000002885.

  38. 38.

    Lichtenstein E, Zhu SH, Tedeschi GJ. Smoking cessation quitlines: an underrecognized intervention success story. The American psychologist. 2010;65(4):252–61. https://doi.org/10.1037/a0018598.

  39. 39.

    Wolfenden L, Wiggers J, Campbell E, Knight J, Kerridge R, Moore K et al. Feasibility, acceptability, and cost of referring surgical patients for postdischarge cessation support from a quitline. Nicotine Tob Res. 2008;10(6):1105–8. doi:https://doi.org/10.1080/14622200802097472.

  40. 40.

    Warner DO, Klesges RC, Dale LC, Offord KP, Schroeder DR, Shi Y et al. Clinician-delivered intervention to facilitate tobacco quitline use by surgical patients. Anesthesiology. 2011;114(4):847–55. doi:https://doi.org/10.1097/ALN.0b013e31820d868d.

  41. 41.

    Scott-Sheldon LA, Lantini R, Jennings EG, Thind H, Rosen RK, Salmoirago-Blotcher E, et al. Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis. JMIR mHealth and uHealth. 2016;4(2):e49. https://doi.org/10.2196/mhealth.5436.

  42. 42.

    Nolan MB, Warner MA, Jacobs MA, Amato MS, Graham AL, Warner DO. Feasibility of a perioperative text messaging smoking cessation program for surgical patients. Anesth Analg. 2019;129(3):e73–e6. https://doi.org/10.1213/ane.0000000000003715.

  43. 43.

    Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5:Cd000146. doi:https://doi.org/10.1002/14651858.CD000146.pub5.

  44. 44.

    Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs. 2010;70(6):643–50. https://doi.org/10.2165/11536100-000000000-00000.

  45. 45.

    Wolfenden L, Wiggers J, Knight J, Campbell E, Rissel C, Kerridge R, et al. A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial. Anaesthesia. 2005;60(2):172–9. https://doi.org/10.1111/j.1365-2044.2004.04070.x.

  46. 46.

    Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY et al. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychol. 2014;33(7):737–47. doi:https://doi.org/10.1037/a0033186.

  47. 47.

    Ratner PA, Johnson JL, Richardson CG, Bottorff JL, Moffat B, Mackay M, et al. Efficacy of a smoking-cessation intervention for elective-surgical patients. Res Nurs Health. 2004;27(3):148–61.

  48. 48.

    Sorensen LT, Hemmingsen U, Jorgensen T. Strategies of smoking cessation intervention before hernia surgery--effect on perioperative smoking behavior. Hernia. 2007;11(4):327–33.

  49. 49.

    Sorensen LT, Jorgensen T. Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Color Dis. 2003;5(4):347–52.

  50. 50.

    Thomsen T, Tonnesen H, Okholm M, Kroman N, Maibom A, Sauerberg ML et al. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial. Nicotine Tob Res. 2010;12(11):1118–24. doi:https://doi.org/10.1093/ntr/ntq158.

  51. 51.

    Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, et al. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial. JAMA Intern Med. 2018;178(5):622–31. https://doi.org/10.1001/jamainternmed.2018.0397.

  52. 52.

    Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335(24):1792–8. https://doi.org/10.1056/nejm199612123352402.

  53. 53.

    Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003;238(1):1–5.

  54. 54.

    Wilkes S. The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis. 2008;3(1):45–53.

  55. 55.

    • Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013(5):Cd009329. doi:https://doi.org/10.1002/14651858.CD009329.pub2. A Cochrane meta-analysis on pharmacotherapy options for smoking cessation.

  56. 56.

    Myles PS, Leslie K, Angliss M, Mezzavia P, Lee L. Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial. Anaesthesia. 2004;59(11):1053–8.

  57. 57.

    Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20. https://doi.org/10.1016/s0140-6736(16)30272-0.

  58. 58.

    Fagerström K, Hughes J. Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat. 2008;4(2):353–63. https://doi.org/10.2147/ndt.s927.

  59. 59.

    Hartmann-Boyce J, Begh R, Aveyard P. Electronic cigarettes for smoking cessation. BMJ (Clinical research ed). 2018;360:j5543. doi:https://doi.org/10.1136/bmj.j5543.

  60. 60.

    Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:Cd010216. doi:https://doi.org/10.1002/14651858.CD010216.pub3.

  61. 61.

    • Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. The New England journal of medicine. 2019;380(7):629–37. doi:https://doi.org/10.1056/NEJMoa1808779. A RCT showing that the use of e-cigarettes was more effective in helping patients achieve 1-year abstinence compared with the use of NRT.

  62. 62.

    Lee SM, Tenney R, Wallace AW, Arjomandi M. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial. PeerJ. 2018;6:e5609. https://doi.org/10.7717/peerj.5609.

  63. 63.

    Kadimpati S, Nolan M, Warner DO. Attitudes, beliefs, and practices regarding electronic nicotine delivery systems in patients scheduled for elective surgery. Mayo Clin Proc. 2015;90(1):71–6. doi:https://doi.org/10.1016/j.mayocp.2014.11.005.

  64. 64.

    • Centers for Disease Control and Prevention. Outbreak of lung injury associated with E-cigarette use, or vaping. 2019. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. A recent report by the CDC regarding cases of lung injury and death associated with the use of e-cigarettes.

  65. 65.

    Wong J, Chung F. Peri-operative cessation of smoking: time for anaesthetists to act. Anaesthesia. 2015;70(8):902–6. https://doi.org/10.1111/anae.13183.

Download references

Author information

Correspondence to Jean Wong.

Ethics declarations

Conflict of Interest

Dong An declares that he has no conflict of interest.

Jean Wong has received research funding from the Ontario Ministry of Health and Long-Term Care, the Anesthesia Patient Safety Foundation, and Merck Canada, and is the recipient of a Merit Research Award from the University of Toronto Department of Anesthesia.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Preoperative Evaluation

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

An, D., Wong, J. Improving Surgical Outcomes and Patient Health: Perioperative Smoking Cessation Interventions. Curr Anesthesiol Rep (2020). https://doi.org/10.1007/s40140-020-00370-0

Download citation

Keywords

  • Smoking cessation
  • Perioperative care